Global Tyrosine Kinase JAK Inhibitors Market Data Survey Report 2025

May 2018 | 73 pages | ID: GF27D660AB1EN
HeyReport

Abstracts

SUMMARY

Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.
The global Tyrosine Kinase JAK Inhibitors market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:

• Global market size and forecast
• Regional market size, production data and export & import
• Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
• Major Application
• Major Type

Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:

• Pfizer
• Incyte
• Novartis
• Eli Lilly
• Gilead
• Sanofi
• Sanofi
• AbbVie
• Vertex
• Teva
• Astellas Pharma
• Celgene
• CTI BioPharma

Major applications as follows:

• Rheumatoid Arthritis (RA)
• Polycythemia Vera (PCV)
• Myelofibrosis (MF)
• Others

Major Type as follows:

• Tofacitinib
• Ruxolitinib
• Baricitinib

Regional market size, production data and Trade:

• Asia-Pacific
• North America
• Europe
• South America
• Middle East & Africa

Contents

1 GLOBAL MARKET OVERVIEW

1.1 Scope of Statistics
  1.1.1 Scope of Products
  1.1.2 Scope of Manufacturers
  1.1.3 Scope of Application
  1.1.5 Scope of Regions/Countries
1.2 Global Market Size

2 REGIONAL MARKET

2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade

3 KEY MANUFACTURERS

3.1 Pfizer
  3.1.2 Company Information
  3.1.2 Product Specifications
  3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Incyte
  3.2.1 Company Information
  3.2.2 Product Specifications
  3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Novartis
  3.3.1 Company Information
  3.3.2 Product Specifications
  3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Eli Lilly
  3.4.1 Company Information
  3.4.2 Product Specifications
  3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Gilead
  3.5.1 Company Information
  3.5.2 Product Specifications
  3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Sanofi
  3.6.1 Company Information
  3.6.2 Product Specifications
  3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Sanofi
  3.7.1 Company Information
  3.7.2 Product Specifications
  3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 AbbVie
  3.8.1 Company Information
  3.8.2 Product Specifications
  3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Vertex
  3.9.1 Company Information
  3.9.2 Product Specifications
  3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 Teva
  3.10.1 Company Information
  3.10.2 Product Specifications
  3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 Astellas Pharma
3.12 Celgene
3.13 CTI BioPharma

4 MAJOR APPLICATION

4.1 Rheumatoid Arthritis (RA)
  4.1.1 Overview
  4.1.2 Rheumatoid Arthritis (RA) Market Size and Forecast
4.2 Polycythemia Vera (PCV)
  4.2.1 Overview
  4.2.2 Polycythemia Vera (PCV) Market Size and Forecast
4.3 Myelofibrosis (MF)
  4.3.1 Overview
  4.3.2 Myelofibrosis (MF) Market Size and Forecast
4.4 Others
  4.4.1 Overview
  4.4.2 Others Market Size and Forecast

5 MARKET BY TYPE

5.1 Tofacitinib
  5.1.1 Overview
  5.1.2 Tofacitinib Market Size and Forecast
5.2 Ruxolitinib
  5.2.1 Overview
  5.2.2 Ruxolitinib Market Size and Forecast
5.3 Baricitinib
  5.3.1 Overview
  5.3.2 Baricitinib Market Size and Forecast

6 CONCLUSION

List Of Tables

LIST OF TABLES

Tab Regional Production 2011-2017 (Million USD)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Million USD)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Tab Sales Revenue, Volume, Price, Cost and Margin of Incyte
Tab Sales Revenue, Volume, Price, Cost and Margin of Novartis
Tab Sales Revenue, Volume, Price, Cost and Margin of Eli Lilly
Tab Sales Revenue, Volume, Price, Cost and Margin of Gilead
Tab Sales Revenue, Volume, Price, Cost and Margin of Sanofi
Tab Sales Revenue, Volume, Price, Cost and Margin of Sanofi
Tab Sales Revenue, Volume, Price, Cost and Margin of AbbVie
Tab Sales Revenue, Volume, Price, Cost and Margin of Vertex
Tab Sales Revenue, Volume, Price, Cost and Margin of Teva
Tab Sales Revenue, Volume, Price, Cost and Margin of Astellas Pharma
Tab Sales Revenue, Volume, Price, Cost and Margin of Celgene
Tab Sales Revenue, Volume, Price, Cost and Margin of CTI BioPharma

List Of Figures

LIST OF FIGURES

Fig Global Tyrosine Kinase JAK Inhibitors Market Size and CAGR 2011-2017 (Million USD)
Fig Global Tyrosine Kinase JAK Inhibitors Market Size and CAGR 2011-2017 (Volume)
Fig Global Tyrosine Kinase JAK Inhibitors Market Forecast and CAGR 2018-2025 (Million USD)
Fig Global Tyrosine Kinase JAK Inhibitors Market Forecast and CAGR 2018-2025 (Volume)
Fig Rheumatoid Arthritis (RA) Market Size and CAGR 2011-2017 (Million USD)
Fig Rheumatoid Arthritis (RA) Market Size and CAGR 2011-2017 (Volume)
Fig Rheumatoid Arthritis (RA) Market Forecast and CAGR 2018-2025 (Million USD)
Fig Rheumatoid Arthritis (RA) Market Forecast and CAGR 2018-2025 (Volume)
Fig Polycythemia Vera (PCV) Market Size and CAGR 2011-2017 (Million USD)
Fig Polycythemia Vera (PCV) Market Size and CAGR 2011-2017 (Volume)
Fig Polycythemia Vera (PCV) Market Forecast and CAGR 2018-2025 (Million USD)
Fig Polycythemia Vera (PCV) Market Forecast and CAGR 2018-2025 (Volume)
Fig Myelofibrosis (MF) Market Size and CAGR 2011-2017 (Million USD)
Fig Myelofibrosis (MF) Market Size and CAGR 2011-2017 (Volume)
Fig Myelofibrosis (MF) Market Forecast and CAGR 2018-2025 (Million USD)
Fig Myelofibrosis (MF) Market Forecast and CAGR 2018-2025 (Volume)
Fig Others Market Size and CAGR 2011-2017 (Million USD)
Fig Others Market Size and CAGR 2011-2017 (Volume)
Fig Others Market Forecast and CAGR 2018-2025 (Million USD)
Fig Others Market Forecast and CAGR 2018-2025 (Volume)
Fig Tofacitinib Market Size and CAGR 2011-2017 (Million USD)
Fig Tofacitinib Market Size and CAGR 2011-2017 (Volume)
Fig Tofacitinib Market Forecast and CAGR 2018-2025 (Million USD)
Fig Tofacitinib Market Forecast and CAGR 2018-2025 (Volume)
Fig Ruxolitinib Market Size and CAGR 2011-2017 (Million USD)
Fig Ruxolitinib Market Size and CAGR 2011-2017 (Volume)
Fig Ruxolitinib Market Forecast and CAGR 2018-2025 (Million USD)
Fig Ruxolitinib Market Forecast and CAGR 2018-2025 (Volume)
Fig Baricitinib Market Size and CAGR 2011-2017 (Million USD)
Fig Baricitinib Market Size and CAGR 2011-2017 (Volume)
Fig Baricitinib Market Forecast and CAGR 2018-2025 (Million USD)
Fig Baricitinib Market Forecast and CAGR 2018-2025 (Volume)